Blood Group-related Antigens in Human Kidney: Modulation of Lewis Determinants in Renal Cell Carcinoma

Cancer Research

Volumn 49, Issue 1, 1989, Pages 212-218

  Cordon Cardo, Carlos ^a   Reuter, Victor E ^a   Finstad, Connie L ^a   Sheinfeld, Joel ^a   Lloyd, Kenneth O ^a   Fair, William R ^a   Melamed, Myron R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

BLOOD GROUP LEWIS SYSTEM; HISTOCHEMISTRY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; PRIORITY JOURNAL;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; CARCINOMA, RENAL CELL; EPITOPES; FEMALE; HISTOLOGICAL TECHNIQUES; HUMAN; KIDNEY; KIDNEY NEOPLASMS; LEWIS BLOOD-GROUP SYSTEM; MALE; MIDDLE AGE; NEOPLASM METASTASIS; NEURAMINIDASE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024530778     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Feizi, T., and Childs, R. A. Carbohydrate structures of glycoproteins and glycolipids as differentiation antigens, tumour-associated antigens and components of receptor systems. Trends. Biochem. Sci., 10: 24-29, 1985.
2. Hakomori, S. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: Overview and perspectives. Cancer Res., 45: 2405-2414,1985.
3. Lloyd, K. O. Blood group antigens as markers for normal and abnormal differentiation and malignant change in human tissues. Am. J. Clin. Pathol., 87: 129-139, 1987.
4. Mourant, A. E. A new blood group antigen of frequent occurrence. Nature Lond. 158:237-239,1946.
5. Andrersen, P. H. The blood group system L. A new blood group L2. A case of epistasy within the blood groups. Acta Pathol. Microbiol. Scand., 25:728-735,1948.
6. Cartron, J. P., Mulet, C., Bauvois, B., Rahuel, C., and Salmon, C. ABH and Lewis glycosyltransferases in human red cells, lymphocytes and platelets. Blood Trans. Immunohematol., 23: 271-280, 1980.
7. Szulman, A. E. The histological distribution of blood group substances A and B in man. J. Exp. Med., III: 785-792, 1960.
8. Szulman, A. E. The histologic distribution of the blood group substances in man as disclosed by immunofluorescence. III. The A, B and H antigens in embryos and fetuses from 18 mm in length. J. Exp. Med., 119: 503-511, 1964.
9. Watanabe, K., Hakomori, S. Status of blood group carbohydrate chains in ontogenesis and oncogenesis. J. Exp. Med., 144:644-656,1976.
10. Sakamoto, J., Yin, B. T., and Lloyd, K. O. Analysis of the expression of H, Lewis, X, Y, and precursor blood group determinants in saliva and red cells using a panel of mouse monoclonal antibodies. Mol. Immunol., 21: 1093-1098, 1984.
11. Bariety, J., Oriol, R., Hinglais, N., Zanetti, M., Bretton, R., Dalix, A. M., and Mandet, C. Distribution of blood group antigen A in normal and pathologic human kidneys. Kidney Int., 17:820-827, 1980.
12. Ernst, C., Atkinson, B., Wysocka, M., Blaszczyk, M., Herlyn, M. Sears, H., Steplewski, Z., and Koprowski, H. Monoclonal antibody localization of Lewis antigens in fixed tissue. Lab. Invest., 50: 394-400,1984.
13. Szulman, A. E., and Marcus, D. M. The histologic distribution of the blood group substances in man as disclosed by immunofluorescence: The Le’ and Lebantigens during fetal development. Lab. Invest., 28:565-574,1973.
14. Combs, S. G., Marder, R. J., Minna, J. D., Mulshine, J. L., Polovina, M. R., and Rosen, S. T. Immunohistochemical localization of the immunodom-inant differentiation antigen lacto-V-fucopentaose III in normal adult and fetal tissues. J. Histochem. Cytochem., 32:982-990, 1984.
15. Fukushi, Y., Hakomori, S., and Shepard, T. Localization and alteration of mono-, di-, and trifucosyl al—>3 type 2 chain structures during human embryogenesis and in human cancer. J. Exp. Med., 160: 506-518, 1984.
16. Hawkins, P., Anderson, S. E., McKenzie, J. L., McLoughlin, K., Beard, M. E., and Hart, D. N. Localization of MN blood group antigens in kidney. Transplant. Proc., 17:1697-1708,1985.
17. Cordon-Cardo, C., Lloyd, K. O., Finstad, C. L., McGroarty, M. E., Reuter, V. E., Bander, N. H., Old, L. J., Melamed, M. R. Immunoanatomic distribution of blood group antigens in the human urinary tract: Influence of secretor status. Lab. Invest., 55:444-454,1986.
18. Bergman, S., Javadpour, N. The cell surface antigen A, B or 0(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report. J. Urol., 119:49-54, 1978.
19. Limas, C., Lange, P., Fraley, E. E., and Vessella, R. L. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with clinical course. Cancer (Phila.), 44:2099-2107,1979.
20. Coon, J. S., McCall, A., Miller, A. W., Farrow, G. M., and Weinstein, R. S. Expression of blood group related antigens in carcinoma “in situ” of the urinary bladder. Cancer (Phila.), 56:797-804,1985.
21. Limas, C., and Lange, P. H. Lewis antigens in normal and neoplastic urothelium. Am. J. Pathol., 121: 176-182,1985.
22. Rettig, W. J., Cordon-Cardo, C., Ng, J. S. C., Oettgen, H. F., Old, L. J., and Lloyd, K. O. High molecular weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res., 45:815-821, 1985.
23. Juhl, B. R., Hartzen, S. H., and Hainau, B. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder. Cancer (Phila.), 57:1768-1775, 1986.
24. Cordon-Cardo, C., Lloyd, K. O., Sakamoto, J., McGroarty, M. E., Old, L. J., and Melamed, M. R. Immunohistologic expression of blood-group antigens in normal human gastrointestinal tract and colonic carcinoma. Int. J. Cancer, 37:667-676,1986.
25. Cordon-Cardo, C., Reuter, V. E., Lloyd, K. O., Sheinfeld, J., Fair, W. R., Old, L. J., and Melamed, M. R. Blood group-related antigens in human urothelium: enhanced expression of precursor, Lex and Le3’ determinants in urothelial carcinoma. Cancer Res., 48:4113-4120, 1988.
26. Hsu, S. M., Raine, L., and Fauger, H. Comparative study of the peroxidase-antiperoxidase and avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Pathol., 75: 734-740, 1981.
27. Juhl, B. R., Norgaard, T., and Bjerrum, O. J. The effect of Tween 20 on indirect immunoperoxidase staining of blood group antigen A in human urothelium. J. Histochem. Cytochem., 32:935-941,1984.
28. Lin, C.-W., Fujime, M., Kirley, S. D., Prout, G. R., Jr. Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex. J. Histochem. Cytochem., 32: 1339-1345, 1984.
29. Limas, C., and Lange, P. H. A, B, H, antigen detectability in normal and neoplastic urothelium: influence of methodologic factors. Cancer (Phila.), 49: 2476-2484, 1982.
30. Seal, G. M., Rowland, R. G., Thomalla, J. V., Rudolph, R. A., Pfaff D. S., Kamer, M., and Eble, J. N. A, B and H antigens in normal urothelium: an immunohistochemical study using monoclonal antibodies with avidin-biotin complex techniques. J. Urol., 133:530-538,1985.
31. Sakamoto, J., Furukawa, K., Cordon-Cardo, C., Old, L. J., and Lloyd, K. O. Expression of Lewis’, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines. Cancer Res., 46:1553-1561,1986.
32. Sarodsky, M. F., and Lamm, D. L. Application of the red cell agglutination test for cell surface antigens to renal cell carcinoma. J. Urol., 128:693-702, 1982.
33. Ghazizadeh, M., Kagawa, S., and Kurokawa, K. Immunohistochemical studies of human renal cell carcinoma for ABO(H) blood group antigens, T antigen-like substance and carcinoembryonic antigen. J. Urol., 133: 762-769,1985.
34. Coon, J. S., and Weinstein, R. S. Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the erythrocyte adherence method. Am. J. Clin. Pathol., 76: 163-169,1981.
35. Weinstein, R. S., Coon, J. S., Alroy, J., and Davidsohn, I. Tissue-associated blood group antigens in human tumors. In: R. A. DeLellis (ed.), Diagnostic Immunohistochemistry, pp. 239-261. New York: Masson Publishing Inc., 1981.
36. Liebert, M., Jaffe, R., Taylor, R. J., Ballou, B. T., Solter, D., and Hakala, T. R. Detection of SSEA-1 on human renal tumors. Cancer (Phila.), 59:1404-1412,1987.
37. Solter, D., and Knowles, B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. USA, 75: 5565-5569,1978.
38. Gooi, H. C., Hounsell, E. F., Edward, S. A., Majdic, O., Knapp, W., and Feizi, T. Differences in the fine specificity of monoclonal (class A) antibodies to human myeloid cells. Clin. Exp. Immunol., 60:151-158,1985.
39. Fleming, S., and Brown, G. The expression of 3-fucosylated-A-acetyl lacto-samine carbohydrate determinants in renal tumors. Histopathology, 11:171—182, 1987.
40. Wallace, A. C., and Nairn, R. C. Renal tubular antigens in kidney tumors. Cancer (Phila.), 29:977-981,1972.
41. Finstad, C. L., Cordon-Cardo, C., Bander, N. H., Whitmore, W. F., Melamed, M. R., and Old, L. J. Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancer. Proc. Natl. Acad. Sci. USA, 82:2955-2959,1985.
42. Holthofer, H., Virtanen, I., Pettersson, E., Tomroth, T., Alfthan, O., Linder, E., and Miettinen, A. Lectins as fluorescence microscopic markers for sac-charides in the human kidney. Lab. Invest., 45:391-398,1981.
43. Ulrich, W., Horvat, R., Krisch, K. Lectin histochemistry of kidney tumours and its pathomorphological relevance. Histopathology, 9:1037-1050,1985.
44. Brown, A., Ellis, I. O., Embleton, M. J., Baldwin, R. W., Turner, D. R., and Hardcastle, J. D. Immunohistochemical localization of Y hapten and the structurally related H type-2 blood antigens on large bowel tumors and normal adult tissues. Int. J. Cancer, 33:727-735,1984.
45. Holmes, E. H., Ostrander, G. K., Hakomori, S. Enzymatic basis for the accumulation of glycolipids with X and dimeric X determinants in human lung cancer cells (NC1-H69). J. Biol. Chem., 260:7619-7624,1985.
46. Hermanek, P., Siegel, A., and Chelpas, A. Histological grading of renal cell carcinomas. Eur. J. Urol., 2:189-197,1976.
47. Mostofl, M. F. (ed.) Histological typing of kidney tumours. Int. Histol. Classification of Tumours, Vol. 25, World Health Organization, 1979.
48. Moon, T. D., Vessella, R. L., Palme, D. F., Nowak, J. A., Lange, P. H. A highly restricted antigen for renal cell carcinoma defined by a monoclonal antibody. Hybridoma, 4:163-169,1985.
49. Oosterwyk, E., Ruiter, J., Wakka, J. C., Huiskens, J. W., Jonas, U., Fleuren, G. J., Zwartendijk, J., Hoedemaeker, P., and Wamaar, S. O. Immunohistochemical analysis of monoclonal antibodies to renal antigens. Am. J. Pathol., 123:301-309,1986.
50. Fukushi, Y., Orikasa, S., Shepard, T., and Hakomori, S. Changes of LeX and dimeric LeX haptens and their sialylated antigens during development of human kidney and kidney tumors. J. Urol., 135:1048-1054,1986.